Vaxart
VXRT
#9395
Rank
โ‚น7.88 B
Marketcap
โ‚น32.87
Share price
-1.43%
Change (1 day)
-38.54%
Change (1 year)

Revenue for Vaxart (VXRT)

Revenue in 2025 (TTM): โ‚น6.90 Billion

According to Vaxart's latest financial reports the company's current revenue (TTM ) is โ‚น7.27 Billion. In 2024 the company made a revenue of โ‚น2.46 Billion an increase over the revenue in the year 2023 that were of โ‚น0.61 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Vaxart from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น6.90 B180.49%
2024 โ‚น2.46 B300.8%
2023 โ‚น0.61 B6837.83%
2022 โ‚น8.85 M-86.66%
2021 โ‚น66.39 M-77.56%
2020 โ‚น0.29 B-57.93%
2019 โ‚น0.70 B141.83%
2018 โ‚น0.29 B-41.61%
2017 โ‚น0.49 B-24.44%
2016 โ‚น0.65 B-25.98%
2015 โ‚น0.89 B-73.24%
2014 โ‚น3.32 B2.49%
2013 โ‚น3.24 B382.81%
2012 โ‚น0.67 B-14.33%
2011 โ‚น0.78 B-49.96%
2010 โ‚น1.56 B222.29%
2009 โ‚น0.48 B
2006 โ‚น3.98 B-11.25%
2005 โ‚น4.48 B-42.39%
2004 โ‚น7.78 B-3.16%
2003 โ‚น8.03 B-14.45%
2002 โ‚น9.39 B-17.06%
2001 โ‚น11.33 B6.12%
2000 โ‚น10.67 B5.14%
1999 โ‚น10.15 B-1.75%
1998 โ‚น10.33 B15.01%
1997 โ‚น8.98 B4.26%
1996 โ‚น8.62 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
NRC Health
NRC
โ‚น12.53 B 72.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Nymox Pharmaceutical
NYMX
N/AN/A Bahamas